PolyPid Ltd. (PYPD), an Israeli biopharmaceutical firm, said on Monday that its Chief Executive Officer or CEO Amir Weisberg, will retire from the service with effect from July 1.
Weisberg will be succeeded by the company's present Chief Financial Officer or CFO Dikla Czaczkes Akselbrad.
Weisberg will direct a transition period with Akselbrad beginning on April 1, and will retire from the helm.
Effective March, PolyPid's Chief Operating Officer or COO Shaul Mukhtar, will also be retiring from the company, following two and a half years term.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.